These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5511953)

  • 1. [Serum-lipid reducing principles--possibilities for treatment. 5. Indications for nicotinic acid and nicotinic acid derivatives].
    Orö L
    Lakartidningen; 1970 Dec; 67():Suppl IV:63+. PubMed ID: 5511953
    [No Abstract]   [Full Text] [Related]  

  • 2. [Does magnesium-orotate improve the effect of lipid lowering drugs?].
    Irsigler K; Flegel U; Kühn P; Schubert H; Iván E; Biro L; Székely L
    Int J Clin Pharmacol; 1973 Aug; 8(1):85-95. PubMed ID: 4727450
    [No Abstract]   [Full Text] [Related]  

  • 3. [The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)].
    Levy H
    Med Klin; 1974 Sep; 69(36):1441-7. PubMed ID: 4280008
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of tocopherol nicotinate on serum lipids].
    Aigner O; Schlick W
    Int J Clin Pharmacol; 1974 Sep; 10(2):124-8. PubMed ID: 4448553
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and metabolic effects of pentaerythritol tetranicotinate(Perycit)and a comparison with plain nicotinic acid.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1974; 19(1):61-73. PubMed ID: 4359183
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and metabolic effects of pentaerythritol tetranicotinate in combination with cholesolvin or clofibrate.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1974; 19(3):407-15. PubMed ID: 4364073
    [No Abstract]   [Full Text] [Related]  

  • 7. [Field study on the decrease of lipids using etofibrate].
    Schneider J; Haase W; Kaffarnik H
    Fortschr Med; 1976 May; 94(13):785-90. PubMed ID: 8362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Basic treatment of coronary atherosclerosis].
    Barrillon A; Binet JP; de Gennes JL; Hazan E; Lenègre J
    Presse Med (1893); 1969 Jun; 77(28):1013-6. PubMed ID: 5795147
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
    Sterner W; Schultz A
    Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360
    [No Abstract]   [Full Text] [Related]  

  • 10. [Arteriosclerosis--nicotinic acid therapy. 6. Treatment of hyperlipemia].
    Orö L
    Lakartidningen; 1971 Apr; 68(15):1758-62. PubMed ID: 5577248
    [No Abstract]   [Full Text] [Related]  

  • 11. [The so-called risk factors in the diurnal profile and following acute alcohol intoxication].
    Hinz G; Pohl W
    Med Welt; 1976 Mar; 27(10):458-62. PubMed ID: 4690
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of one-year treatment with slow-release nicotinic acid. Monitoring of drug concentration in serum.
    Chojnowska-Jezierska J; Adamska-Dyniewska H
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):326-32. PubMed ID: 9660040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic effect of Ciba 13437-Su in 40 patients with familial essential hyperlipemia].
    Schönbeck M; Forster G; Hirzel H; Jakab T; Rosenmund H
    Dtsch Med Wochenschr; 1970 Aug; 95(35):1761-8. PubMed ID: 5451984
    [No Abstract]   [Full Text] [Related]  

  • 14. [Arteriosclerosis--nicotinic acid therapy. 3. Lipolytic effects of nicotinic acid and its derivatives].
    Lundholm L
    Lakartidningen; 1971 Apr; 68(15):1746-9. PubMed ID: 5577245
    [No Abstract]   [Full Text] [Related]  

  • 15. [Why take fasting blood samples for laboratory diagnosis? Behavior of various laboratory parameters in postprandial blood samples].
    Bloedner CD
    Fortschr Med; 1984 Nov; 102(44):1123-7. PubMed ID: 6151934
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the problems of the consumption of alcohol in the brewing industry (author's transl)].
    Zober A; Bost HP; Weltle D
    Zentralbl Bakteriol B; 1979 Jun; 168(5-6):422-41. PubMed ID: 41383
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of chenodesoxycholic acid on serum lipids and enzymes (transaminases) in patients with biliary lithiasis].
    Bataller Sifre R; Pascual Bataller E; Rosique Martínez A; Miralles Espi MC
    Rev Esp Enferm Apar Dig; 1982 Feb; 61(2):141-4. PubMed ID: 7089362
    [No Abstract]   [Full Text] [Related]  

  • 18. [Arteriosclerosis--nicotinic acid therapy. 7. Effect of nicotinic acid on lipoproteins].
    Carlson LA
    Lakartidningen; 1971 Apr; 68(15):1763-4. PubMed ID: 5577249
    [No Abstract]   [Full Text] [Related]  

  • 19. [Assessment of health status and metabolic parameters of cosmonauts during space flight].
    Grigor'ev AI; Poliakov VV; Noskov VB; Kozharinov VI
    Kosm Biol Aviakosm Med; 1991; 25(6):48-9. PubMed ID: 8577167
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral glucose tolerance, plasma insulin, and uric acid excretion in man during chronic administration of nicotinic acid.
    Gaut ZN; Pocelinko R; Solomon HM; Thomas GB
    Metabolism; 1971 Nov; 20(11):1031-5. PubMed ID: 5115752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.